+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ulcerative Colitis (Gastrointestinal) - Drugs In Development, 2021

  • ID: 5402592
  • Report
  • July 2021
  • Region: Global
  • 941 Pages
  • Global Markets Direct
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • 180 Life Corp
  • 4D Pharma Plc
  • 9 Meters Biopharma Inc
  • AbbVie Inc
  • Abivax SA
  • Aclaris Therapeutics Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Drugs In Development, 2021, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.

Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory Bowel Disease (IBD). The disease is characterized by open sores and ulcers in the colon. The risk factors for UC include smoking, family history of the disease, liver disease, colon cancer, depression, and severe dehydration. Common symptoms of ulcerative colitis include rectal bleeding, abdominal pain, and diarrhea. Treatment options for ulcerative colitis include surgery (removal of colon) or drug therapy with aminoasylates (ASA), immunomodulators, and corticosteroids.

Report Highlights


The publisher's Pharmaceutical and Healthcare latest pipeline guide Ulcerative Colitis - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Ulcerative Colitis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Ulcerative Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Ulcerative Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 7, 12, 56, 44, 4, 93 and 35 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 12 molecules, respectively.

Ulcerative Colitis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope


  • The pipeline guide provides a snapshot of the global therapeutic landscape of Ulcerative Colitis (Gastrointestinal).
  • The pipeline guide reviews pipeline therapeutics for Ulcerative Colitis (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Ulcerative Colitis (Gastrointestinal) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Ulcerative Colitis (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Ulcerative Colitis (Gastrointestinal)

Reasons to Buy


  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Ulcerative Colitis (Gastrointestinal).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Ulcerative Colitis (Gastrointestinal) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 180 Life Corp
  • 4D Pharma Plc
  • 9 Meters Biopharma Inc
  • AbbVie Inc
  • Abivax SA
  • Aclaris Therapeutics Inc

Introduction
Ulcerative Colitis - Overview
  • Ulcerative Colitis - Therapeutics Development
Ulcerative Colitis - Therapeutics AssessmentUlcerative Colitis - Companies Involved in Therapeutics DevelopmentUlcerative Colitis - Drug ProfilesUlcerative Colitis - Dormant ProjectsUlcerative Colitis - Discontinued ProductsUlcerative Colitis - Product Development MilestonesAppendix
List of Tables
  • Number of Products under Development for Ulcerative Colitis, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Products under Development by Companies, 2021
  • Products under Development by Universities/Institutes, 2021
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Ulcerative Colitis - Pipeline by 180 Life Corp, 2021
  • Ulcerative Colitis - Pipeline by 4D Pharma Plc, 2021
  • Ulcerative Colitis - Pipeline by 9 Meters Biopharma Inc, 2021
  • Ulcerative Colitis - Pipeline by AbbVie Inc, 2021
  • Ulcerative Colitis - Pipeline by Abivax SA, 2021
  • Ulcerative Colitis - Pipeline by Accro BioScience (Suzhou) Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Aclaris Therapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by Affilogic SAS, 2021
  • Ulcerative Colitis - Pipeline by Akebia Therapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by Akeso Inc, 2021
  • Ulcerative Colitis - Pipeline by Algernon Pharmaceuticals Inc, 2021
  • Ulcerative Colitis - Pipeline by Alpha Cancer Technologies Inc, 2021
  • Ulcerative Colitis - Pipeline by AltruBio Inc, 2021
  • Ulcerative Colitis - Pipeline by Alvotech ehf, 2021
  • Ulcerative Colitis - Pipeline by Am-Pharma BV, 2021
  • Ulcerative Colitis - Pipeline by Amgen Inc, 2021
  • Ulcerative Colitis - Pipeline by Amide Technologies Inc, 2021
  • Ulcerative Colitis - Pipeline by Apidel SA, 2021
  • Ulcerative Colitis - Pipeline by Applied Molecular Transport Inc, 2021
  • Ulcerative Colitis - Pipeline by Arena Pharmaceuticals Inc, 2021
  • Ulcerative Colitis - Pipeline by Artelo Biosciences Inc, 2021
  • Ulcerative Colitis - Pipeline by AsiaBiome, 2021
  • Ulcerative Colitis - Pipeline by Asta Pharmaceuticals Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by AstraZeneca Plc, 2021
  • Ulcerative Colitis - Pipeline by Atlantic Healthcare Plc, 2021
  • Ulcerative Colitis - Pipeline by Avesthagen Ltd, 2021
  • Ulcerative Colitis - Pipeline by Avexegen Therapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by Axim Biotechnologies Inc, 2021
  • Ulcerative Colitis - Pipeline by AzurRx BioPharma Inc, 2021
  • Ulcerative Colitis - Pipeline by Bacainn Therapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by BenevolentAI Ltd, 2021
  • Ulcerative Colitis - Pipeline by Bilix Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Bio-Thera Solutions Ltd, 2021
  • Ulcerative Colitis - Pipeline by BioGaia AB, 2021
  • Ulcerative Colitis - Pipeline by BioXpress Therapeutics SA, 2021
  • Ulcerative Colitis - Pipeline by Boehringer Ingelheim International GmbH, 2021
  • Ulcerative Colitis - Pipeline by Bridge Biotherapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by Bristol Myers Squibb Co, 2021
  • Ulcerative Colitis - Pipeline by Captor Therapeutics SA, 2021
  • Ulcerative Colitis - Pipeline by Finch Therapeutics Group Inc, 2021
  • Ulcerative Colitis - Pipeline by First Wave Bio Inc, 2021
  • Ulcerative Colitis - Pipeline by FYB 202 GmbH & Co KG, 2021
  • Ulcerative Colitis - Pipeline by Fzata Inc, 2021
  • Ulcerative Colitis - Pipeline by Galapagos NV, 2021
  • Ulcerative Colitis - Pipeline by Genentech USA Inc, 2021
  • Ulcerative Colitis - Pipeline by Genor BioPharma Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Giiant Pharma Inc, 2021
  • Ulcerative Colitis - Pipeline by GlaxoSmithKline Plc, 2021
  • Ulcerative Colitis - Pipeline by GLW Pharma, 2021
  • Ulcerative Colitis - Pipeline by Gossamer Bio Inc, 2021
  • Ulcerative Colitis - Pipeline by Guangzhou Magpie Pharmaceutical Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Gusto Global LLC, 2021
  • Ulcerative Colitis - Pipeline by Hefei Cosource Pharmaceutical Inc, 2021
  • Ulcerative Colitis - Pipeline by Hillhurst Biopharmaceuticals Inc, 2021
  • Ulcerative Colitis - Pipeline by Himuka AM Pharma Corp, 2021
  • Ulcerative Colitis - Pipeline by Holy Stone Healthcare Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Hoth Therapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by Huabo Biopharm (Shanghai) Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Ichnos Sciences Inc, 2021
  • Ulcerative Colitis - Pipeline by Iltoo Pharma, 2021
  • Ulcerative Colitis - Pipeline by Immix BioPharma Inc, 2021
  • Ulcerative Colitis - Pipeline by Immunic Inc, 2021
  • Ulcerative Colitis - Pipeline by Impetis Biosciences Ltd, 2021
  • Ulcerative Colitis - Pipeline by Inception Sciences Inc, 2021
  • Ulcerative Colitis - Pipeline by InDex Pharmaceuticals Holding AB, 2021
  • Ulcerative Colitis - Pipeline by Innovation Pharmaceuticals Inc, 2021
  • Ulcerative Colitis - Pipeline by Innovative Pharmacological Research (IPHAR) Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Innovimmune Biotherapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by InSight Biopharmaceuticals Ltd, 2021
  • Ulcerative Colitis - Pipeline by Intact Therapeutics, 2021
  • Ulcerative Colitis - Pipeline by Intas Pharmaceuticals Ltd, 2021
  • Ulcerative Colitis - Pipeline by Intract Pharma Ltd, 2021
  • Ulcerative Colitis - Pipeline by Istesso Ltd, 2021
  • Ulcerative Colitis - Pipeline by Janux Therapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by Jiangsu Carephar Pharmaceutical Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Jiangsu Hansoh Pharmaceutical Group Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Johnson & Johnson, 2021
  • Ulcerative Colitis - Pipeline by Kaleido Biosciences Inc, 2021
  • Ulcerative Colitis - Pipeline by Kiniksa Pharmaceuticals Ltd, 2021
  • Ulcerative Colitis - Pipeline by KoBioLabs Inc, 2021
  • Ulcerative Colitis - Pipeline by Korea Pharma Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Koutif Therapeutics LLC, 2021
  • Ulcerative Colitis - Pipeline by Kyorin Pharmaceutical Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Landos Biopharma Inc, 2021
  • Ulcerative Colitis - Pipeline by LegoChem Biosciences Inc, 2021
  • Ulcerative Colitis - Pipeline by LG Chem Ltd, 2021
  • Ulcerative Colitis - Pipeline by LTT Bio-Pharma Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by MAKScientific LLC, 2021
  • Ulcerative Colitis - Pipeline by Merck & Co Inc, 2021
  • Ulcerative Colitis - Pipeline by Mesoblast Ltd, 2021
  • Ulcerative Colitis - Pipeline by Metacrine Inc, 2021
  • Ulcerative Colitis - Pipeline by Metagen Therapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by Microbiotica Ltd, 2021
  • Ulcerative Colitis - Pipeline by Mitsubishi Tanabe Pharma Corp, 2021
  • Ulcerative Colitis - Pipeline by Morphic Therapeutic Inc, 2021
  • Ulcerative Colitis - Pipeline by MRM Health NV, 2021
  • Ulcerative Colitis - Pipeline by Nano Intelligent Biomedical Engineering Corp, 2021
  • Ulcerative Colitis - Pipeline by Nektar Therapeutics, 2021
  • Ulcerative Colitis - Pipeline by NeuClone Pty Ltd, 2021
  • Ulcerative Colitis - Pipeline by Nexel Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Novan Inc, 2021
  • Ulcerative Colitis - Pipeline by Novartis AG, 2021
  • Ulcerative Colitis - Pipeline by Novellus Therapeutics Ltd, 2021
  • Ulcerative Colitis - Pipeline by Novome Biotechnologies Inc, 2021
  • Ulcerative Colitis - Pipeline by Nubiyota LLC, 2021
  • Ulcerative Colitis - Pipeline by Numedii Inc, 2021
  • Ulcerative Colitis - Pipeline by Nyrada Inc, 2021
  • Ulcerative Colitis - Pipeline by Oncodesign SA, 2021
  • Ulcerative Colitis - Pipeline by Oncostellae SL, 2021
  • Ulcerative Colitis - Pipeline by Oryn Therapeutics, 2021
  • Ulcerative Colitis - Pipeline by OSE Immunotherapeutics, 2021
  • Ulcerative Colitis - Pipeline by Ovamed GmbH, 2021
  • Ulcerative Colitis - Pipeline by Palatin Technologies Inc, 2021
  • Ulcerative Colitis - Pipeline by Palo BioFarma SL, 2021
  • Ulcerative Colitis - Pipeline by PanTheryx Inc, 2021
  • Ulcerative Colitis - Pipeline by Paradigm Biopharmaceuticals Ltd, 2021
  • Ulcerative Colitis - Pipeline by Pfizer Inc, 2021
  • Ulcerative Colitis - Pipeline by Pharmabiome AG, 2021
  • Ulcerative Colitis - Pipeline by Pharmapraxis, 2021
  • Ulcerative Colitis - Pipeline by Pharmaxis Ltd, 2021
  • Ulcerative Colitis - Pipeline by PNB Vesper Life Science Pvt Ltd, 2021
  • Ulcerative Colitis - Pipeline by Praeventix LLC, 2021
  • Ulcerative Colitis - Pipeline by Progenity Inc, 2021
  • Ulcerative Colitis - Pipeline by Prometheus Biosciences Inc, 2021
  • Ulcerative Colitis - Pipeline by Protab Ltd, 2021
  • Ulcerative Colitis - Pipeline by Protagonist Therapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by Protalix BioTherapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by Provention Bio Inc, 2021
  • Ulcerative Colitis - Pipeline by Puretech Health Plc, 2021
  • Ulcerative Colitis - Pipeline by Qu Biologics Inc, 2021
  • Ulcerative Colitis - Pipeline by Re-Pharm Ltd, 2021
  • Ulcerative Colitis - Pipeline by Rebiotix Inc, 2021
  • Ulcerative Colitis - Pipeline by Regentys Corp, 2021
  • Ulcerative Colitis - Pipeline by Reistone Biopharma Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by RhemaStem SRLS, 2021
  • Ulcerative Colitis - Pipeline by Rhizen Pharmaceuticals SA, 2021
  • Ulcerative Colitis - Pipeline by Salix Pharmaceuticals Ltd, 2021
  • Ulcerative Colitis - Pipeline by Samsung Bioepis Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Saniona AB, 2021
  • Ulcerative Colitis - Pipeline by Santhera Pharmaceuticals Holding AG, 2021
  • Ulcerative Colitis - Pipeline by Sareum Holdings Plc, 2021
  • Ulcerative Colitis - Pipeline by Semorex Technologies Ltd, 2021
  • Ulcerative Colitis - Pipeline by Senda Biosciences Inc, 2021
  • Ulcerative Colitis - Pipeline by Seres Therapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by Servatus Ltd, 2021
  • Ulcerative Colitis - Pipeline by Shanghai Jiyu Pharmaceutical Technology Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Shaperon Inc, 2021
  • Ulcerative Colitis - Pipeline by Siam Bioscience Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by StemRIM Inc, 2021
  • Ulcerative Colitis - Pipeline by sterna biologicals Gmbh & Co KG, 2021
  • Ulcerative Colitis - Pipeline by Sublimity Therapeutics HoldCo Ltd, 2021
  • Ulcerative Colitis - Pipeline by Suono Bio Inc, 2021
  • Ulcerative Colitis - Pipeline by Surrozen Inc, 2021
  • Ulcerative Colitis - Pipeline by Suzhou Connect Biopharmaceuticals Ltd, 2021
  • Ulcerative Colitis - Pipeline by Swedish Orphan Biovitrum AB, 2021
  • Ulcerative Colitis - Pipeline by Synedgen Inc, 2021
  • Ulcerative Colitis - Pipeline by Synlogic Inc, 2021
  • Ulcerative Colitis - Pipeline by Takeda Pharmaceutical Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Tarus Therapeutics Inc, 2021
  • Ulcerative Colitis - Pipeline by TheraSource LLC, 2021
  • Ulcerative Colitis - Pipeline by Theravance Biopharma Inc, 2021
  • Ulcerative Colitis - Pipeline by Thetis Pharmaceuticals LLC, 2021
  • Ulcerative Colitis - Pipeline by Tianjin Hemay Pharmaceutical Co Ltd, 2021
  • Ulcerative Colitis - Pipeline by Tillotts Pharma AG, 2021
  • Ulcerative Colitis - Pipeline by TopiVert Ltd, 2021
  • Ulcerative Colitis - Pipeline by Torrent Pharmaceuticals Ltd, 2021
  • Ulcerative Colitis - Pipeline by Vedanta Biosciences Inc, 2021
  • Ulcerative Colitis - Pipeline by Ventyx Biosciences Inc, 2021
  • Ulcerative Colitis - Pipeline by Vivreon Biosciences LLC, 2021
  • Ulcerative Colitis - Pipeline by Voronoi Group, 2021
  • Ulcerative Colitis - Pipeline by Zhiyi Pharmaceuticals Inc, 2021
  • Ulcerative Colitis - Dormant Projects, 2021
  • Ulcerative Colitis - Discontinued Products, 2021

List of Figures
  • Number of Products under Development for Ulcerative Colitis, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Top 10 Routes of Administration, 2021
  • Number of Products by Stage and Top 10 Routes of Administration, 2021
  • Number of Products by Top 10 Molecule Types, 2021
  • Number of Products by Stage and Top 10 Molecule Types, 2021
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • 180 Life Corp
  • 4D Pharma Plc
  • 9 Meters Biopharma Inc
  • AbbVie Inc
  • Abivax SA
  • Accro BioScience (Suzhou) Co Ltd
  • Aclaris Therapeutics Inc
  • Affilogic SAS
  • Akebia Therapeutics Inc
  • Akeso Inc
  • Algernon Pharmaceuticals Inc
  • Alpha Cancer Technologies Inc
  • Amide Technologies Inc
Note: Product cover images may vary from those shown